FDA permits marketing of artificial intelligence-based device to detect certain diabetes

FDA permits marketing of artificial intelligence-based device to detect certain diabetes

  • April 13, 2018
Table of Contents

FDA permits marketing of artificial intelligence-based device to detect certain diabetes

The U.S. Food and Drug Administration today permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes.

Source: fda.gov

Share :
comments powered by Disqus

Related Posts

Towards a Virtual Stuntman

Towards a Virtual Stuntman

Motion control problems have become standard benchmarks for reinforcement learning, and deep RL methods have been shown to be effective for a diverse suite of tasks ranging from manipulation to locomotion. However, characters trained with deep RL often exhibit unnatural behaviours, bearing artifacts such as jittering, asymmetric gaits, and excessive movement of limbs. Can we train our characters to produce more natural behaviours?

Read More
Project Clara: NVIDIA Supercomputing Platform Redefines Medical Imaging

Project Clara: NVIDIA Supercomputing Platform Redefines Medical Imaging

NVIDIA’s Project Clara, a medical imaging supercomputer, renews the capabilities of these machines in place. Unveiled this week at the GPU Technology Conference, in Silicon Valley, Project Clara takes advantage of incredible advancements in computation.

Read More